Table 1.
Factors with a strong genetic component | |
---|---|
Elevated levels of LDL/VLDL | Associations demonstrated in epidemiological studies and supported by studies of genetic disorders and animal models. Clinical trials have shown benefits of cholesterol reduction54. |
Reduced levels of HDL | Associations demonstrated by numerous epidemiological studies and supported by studies of genetic diseases and animal models58. |
Elevated levels of lipoprotein(a) | Associations observed in many, but not all, epidemiological studies. Animal studies have been contradictory59. |
Elevated blood pressure | Associations observed in epidemiological studies. Clinical trials have demonstrated benefits of blood pressure reduction, with particularly strong effects on stroke54,60. |
Elevated levels of homocysteine | Associations have been observed in epidemiological studies, and homocystinuria results in severe occlusive vascular disease36. |
Family history | When all known risk factors are controlled for, family history remains a very significant independent factor6. |
Diabetes and obesity | Associations observed in epidemiological studies and in studies with animal models54. |
Elevated levels of haemostatic factors | Significant independent associations have been observed with elevated levels of fibrinogen, plasminogen activator inhibitor type 1 and platelet reactivity54. |
Depression and other behavioural traits | Associations observed in several population studies61. |
Gender (male) | Below age 60, men develop CHD at more than twice the rate of women38. |
Systemic inflammation | Elevated levels of inflammatory molecules such as C-reactive protein are associated with CHD, as are inflammatory diseases such as rheumatoid arthritis62. |
Metabolic syndrome | This cluster of metabolic disturbances, with insulin resistance as a central feature, is strongly associated with CHD5. |
Environmental factors | |
---|---|
High-fat diet | Population migration and epidemiological studies indicate strong associations with lifestyle, and diet appears to be the most significant factor. High-fat, high-cholesterol diets are usually required for development of atherosclerosis in experimental animals54. |
Smoking | Strong associations observed in numerous epidemiological studies. Clinical trials have demonstrated the benefit of stopping smoking54. |
Low antioxidant levels | Results of clinical trials with antioxidants have not been conclusive. Fat-soluble antioxidants protect against atherosclerosis in experimental animals, however63. |
Lack of exercise | Significant independent associations with CHD54. |
Infectious agents | Epidemiological studies provide suggestive evidence for associations with various infectious agents, such as Chlamydia pneumoniae. Preliminary animal studies support the relationship64. |